SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-038298
Filing Date
2023-10-25
Accepted
2023-10-25 17:26:30
Documents
88
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2123213
2 ex4-1.htm EX-4.1 10531
3 ex31-1.htm EX-31.1 17285
4 ex31-2.htm EX-31.2 10322
5 ex32-1.htm EX-32.1 4330
6 ex32-2.htm EX-32.2 4305
7 form10-k_0001.jpg GRAPHIC 86579
8 form10-k_001.jpg GRAPHIC 22654
9 form10-k_002.jpg GRAPHIC 26118
10 form10-k_003.jpg GRAPHIC 58370
11 aud_001.jpg GRAPHIC 1746
  Complete submission text file 0001493152-23-038298.txt   8475075

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE bctx-20230731.xsd EX-101.SCH 53226
13 XBRL CALCULATION FILE bctx-20230731_cal.xml EX-101.CAL 53040
14 XBRL DEFINITION FILE bctx-20230731_def.xml EX-101.DEF 222656
15 XBRL LABEL FILE bctx-20230731_lab.xml EX-101.LAB 384805
16 XBRL PRESENTATION FILE bctx-20230731_pre.xml EX-101.PRE 311992
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1367249
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 001-40101 | Film No.: 231346919
SIC: 2834 Pharmaceutical Preparations